Full Text View
Tabular View
No Study Results Posted
Related Studies
Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder
This study has been completed.
Study NCT00383786   Information provided by National Institutes of Health Clinical Center (CC)

First Received on October 3, 2006.   Last Updated on September 16, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
PTSD
Additional conditions recognized in this trial
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
More general conditions related to this trial
Anxiety Disorders
Mental Disorders
Interventions listed in this trial
NK1 Antagoist (GR205171)
Psychophysiology (Trauma Script)
Psychophysiology (Verbal Threat)
Lumbar Puncture
24-hour plasma sampling
MRI
GR205171
Additional drug interventions recognized in this trial
GR 205171
Substance P
More general drug interventions related to this trial
Antiemetics
Autonomic Agents
Central Nervous System Agents
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services